The prestigious Conference on Retroviruses and Opportunistic Infections (CROI) is open to researchers and clinical educators working in this space, the 2024 event will be held in-person in Denver, Colorado, from 3-6 March.
For us, CROI is a crucial forum in our efforts to leave no person living with HIV behind by providing findings and insights to the wider community of scientists and healthcare professionals. Abstracts from our innovative pipeline and portfolio will reinforce our commitment to the evolving needs of the HIV community, including presenting new data and findings for the next generation of HIV medicines. Despite advances in HIV treatment, we won’t stop innovating. We want to better the quality of life for people living with and impacted by HIV. To do that we prioritise developing medicines that fit their lifestyle. We know that the needs of people living with HIV change over time, and we’re exploring new ways of treating and preventing HIV through new approaches in how we target the virus as well as our delivery process.
Hear from our scientists to find out more about our commitment to developing a variety of different treatment and prevention options for people living with HIV.
YOU MAY ALSO BE INTERESTED IN
The process of identifying, creating and developing generally well-tolerated and effective innovative HIV therapies is complex and requires ongoing collaboration between research teams that work in many different areas of medicines development.
Thanks to advances in science and innovation, people living with HIV have options for effective treatment that mean they can expect to live long and healthy lives. Find out why understanding the needs and wants of people living with HIV is essential.
Discover the importance of representative research for HIV treatment for people living with HIV
NP-GBL-HVX-COCO-230001 February 2024
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.
